You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 22, 2026

AMLODIPINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for AMLODIPINE?
  • What are the global sales for AMLODIPINE?
  • What is Average Wholesale Price for AMLODIPINE?
Drug patent expirations by year for AMLODIPINE
Drug Prices for AMLODIPINE

See drug prices for AMLODIPINE

Drug Sales Revenue Trends for AMLODIPINE

See drug sales revenues for AMLODIPINE

US Patents and Regulatory Information for AMLODIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 078021-003 Jul 17, 2007 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Macleods Pharms Ltd AMLODIPINE BESYLATE AND VALSARTAN amlodipine besylate; valsartan TABLET;ORAL 207292-003 Oct 11, 2024 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Aurobindo Pharma Ltd AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 202239-006 Sep 5, 2012 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Hikma AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 077262-003 Jul 9, 2007 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Heritage AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 091431-001 Dec 30, 2013 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Sciegen Pharms AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 209010-001 Dec 3, 2018 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.